| Literature DB >> 25859871 |
Mehmet Salih Aydin1, Aydemir Kocarslan1, Sezen Kocarslan2, Ahmet Kucuk3, İrfan Eser3, Hatice Sezen4, Evren Buyukfirat5, Abdussemet Hazar1.
Abstract
INTRODUCTION: Previous studies have demonstrated that thymoquinone has protective effects against ischemia reperfusion injury to various organs like lungs, kidneys and liver in different experimental models.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25859871 PMCID: PMC4389520 DOI: 10.5935/1678-9741.20140066
Source DB: PubMed Journal: Rev Bras Cir Cardiovasc
Oxidative and antioxidative parameters and histopathological evaluation in Sham, Control and TQ + I/R rats.
| Sham | Control | TQ+I/R | ||
|---|---|---|---|---|
| (n=10) | (n=10) | (n=10) | ||
| TAC (nmolTroloxEqv./mg protein) | 1.39±0.18 | 0.53±0.12 | 0.65±0.12 | |
| TOS (nmol H2O2 Eqv./ mg protein) | 28.3±8.5 | 44.1±8.1 | 25.8±2.3 | |
| OSI (arbitrary units) | 2.0±0.44 | 8.35±1.23 | 1.30±0.41 | |
| Renal Pathology score | 1.7±1.25 | 4.4±0.69 | 2.1±1.37 | |
| Lung Pathology score | 1.7±1.15 | 4.6±0.51 | 3.0±1.24 | |
| Heart Pathology score | 0.3±0.48 | 1.5±0.52 | 0.9±0.73 |
TAC=Total Antioxidant Capacity; TOS=Total Oxidant Status; OSI=Oxidative Stress Index P<0.05 was considered as statistically significant.
P<0.001 (for all comparisons) compared with I/R and TQ+I/R
P<0.001 (for all comparisons) compared with sham and TQ+I/R
Fig. 1TAC levels for sham, control, and thymoquinine groups. * P<0.001 (for all comparisons) compared with I/R and I/R+TQ
Fig. 2TOS levels in sham, control, and thymoquinine groups. + P<0.001 (for all comparisons) compared with sham and thymoquinine groups
Fig. 3OSI levels in sham, control, and thymoquinine groups. +P<0.001 (for all comparisons) compared with sham and thymoquinine groups
Fig. 4A and D show renal and lung tissues samples of the sham group and there were no pathological changes. B) shows lung tissues samples of control group and neutrophil and leukocyte infiltration with alveolar congestion were observed. E) shows renal tissues samples of control group and tubular damage characterized by cast formation; the loss of brush border and interstitial edema were observed. C and F show lung and renal tissues samples of thymoquinine treated group and there were less severe lesions than in the control group.
| Abbreviations, acronyms & symbols | |
|---|---|
| I/R | Ischemia-Reperfusion |
| OSI | Oxidative Stress Index |
| ROS | Reactive Oxygen Species |
| TAC | Total Antioxidant Capacity |
| TOS | Total Oxidant Status |
| TQ | Thymoquinone |
| Authors’ roles & responsibilities | |
|---|---|
| MSA | Analysis and /or interpretation of data, statistical analysis, final approval of the manuscript conception and study design, conduct of procedures, and/or experiments, writing of the manuscript or review of its content |
| AK | Analysis and/or interpretation of data, final approval of manuscript |
| SK | Statistical analysis, conception and study design, conduct of procedures, and/or experiments |
| AK | Conduct of procedures and/or experiments, writing of the manuscript or review of its content |
| IE | Statistical analysis, final approval of manuscript |
| HS | Statistical analysis, final approval of the manuscript, conception and study design, conduct of procedures, and/or experiments |
| EB | Statistical analysis, final approval of the manuscript, drafting the manuscript or revising it critically for its content |
| AH | Drafting of the manuscript or review of its content |